首页> 外文期刊>Glycoconjugate journal >Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification
【24h】

Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification

机译:通过亲和富集和质谱鉴定对肝癌细胞的表面糖蛋白组学分析

获取原文
获取原文并翻译 | 示例
           

摘要

Cell surface glycoproteins are one of the most frequently observed phenomena correlated with malignant growth. Hepatocellular carcinoma (HCC) is one of the most malignant tumors in the world. The majority of hepatocellular carcinoma cell surface proteins are modified by glycosylation in the process of tumor invasion and metastasis. Therefore, characterization of cell surface glycoproteins can provide important information for diagnosis and treatment of liver cancer, and also represent a promising source of potential diagnostic biomarkers and therapeutic targets for hepatocellular carcinoma. However, cell surface glycoproteins of HCC have been seldom identified by proteomics approaches because of their hydrophobic nature, poor solubility, and low abundance. The recently developed cell surface-capturing (CSC) technique was an approach specifically targeted at membrane glycoproteins involving the affinity capture of membrane glycoproteins using glycan biotinylation labeling on intact cell surfaces. To characterize the cell surface glycoproteome and probe the mechanism of tumor invasion and metastasis of HCC, we have modified and evaluated the cell surface-capturing strategy, and applied it for surface glycoproteomic analysis of hepatocellular carcinoma cells. In total, 119 glycosylation sites on 116 unique glycopeptides were identified, corresponding to 79 different protein species. Of these, 65 (54.6 %) new predicted glycosylation sites were identified that had not previously been determined experimentally. Among the identified glycoproteins, 82 % were classified as membrane proteins by a database search, 68 % had transmembrane domains (TMDs), and 24 % were predicted to contain 2-13 TMDs. Moreover, a total of 26 CD antigens with 50 glycopeptides were detected in the membrane glycoproteins of hepatocellular carcinoma cells, comprising 43 % of the total glycopeptides identified. Many of these identified glycoproteins are associated with cancer such as CD44, CD147 and EGFR. This is a systematic characterization of cell surface glycoproteins of HCC. The membrane glycoproteins identified in this study provide very useful information for probing the mechanism of liver cancer invasion and metastasis.
机译:细胞表面糖蛋白是与恶性生长相关的最常观察到的现象之一。肝细胞癌(HCC)是世界上最恶性的肿瘤之一。在肿瘤侵袭和转移过程中,大多数肝细胞癌细胞表面蛋白被糖基化修饰。因此,细胞表面糖蛋白的表征可以为肝癌的诊断和治疗提供重要的信息,也代表了肝细胞癌潜在的诊断生物标志物和治疗靶标的有希望的来源。然而,由于其疏水性,差的溶解性和低丰度,很少通过蛋白质组学方法鉴定HCC的细胞表面糖蛋白。最近开发的细胞表面捕获(CSC)技术是一种专门针对膜糖蛋白的方法,涉及使用完整细胞表面上的聚糖生物素化标记对膜糖蛋白进行亲和力捕获。为了表征细胞表面糖蛋白组学和探索肝癌的肿瘤侵袭和转移的机制,我们已经修改和评估了细胞表面捕获策略,并将其应用于肝细胞癌细胞的表面糖蛋白组学分析。总共鉴定出116个独特糖肽上的119个糖基化位点,对应于79种不同的蛋白质种类。其中,鉴定了65个(54.6%)新的预测糖基化位点,这些位点以前从未通过实验确定。在鉴定出的糖蛋白中,有82%的糖蛋白通过数据库搜索被归类为膜蛋白,68%的蛋白具有跨膜结构域(TMD),而24%的蛋白被预测包含2-13个TMD。此外,在肝癌细胞的膜糖蛋白中检测到总共26种带有50个糖肽的CD抗原,占鉴定出的糖肽总量的43%。这些鉴定出的糖蛋白中有许多与癌症有关,例如CD44,CD147和EGFR。这是肝癌细胞表面糖蛋白的系统表征。在这项研究中确定的膜糖蛋白为探索肝癌的侵袭和转移机制提供了非常有用的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号